secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axogen, Inc. (AXGN)
CIK:        0000805928
Form:       8-K
Filed at:   2024-03-08T23:59:59+00:00
Accession:  0000805928-24-000037
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axogen Chief R&D Officer Scopelianos resigns; transition consulting through Dec 2024
--------------------------------------------------------------------------------

- Angelo Scopelianos resigns as Chief R&D Officer effective no later than March 31, 2024.
- He will consult up to 10 hrs/wk from Apr 1 to Dec 31, 2024 for $9,079.16/month plus a $75,000 one-time payment if through Oct 1.
- Scopelianos receives his 2023 bonus of $228,385.26 on March 15, 2024.
- Unvested stock options continue vesting through consulting period; RSUs and unvested PSUs cease at separation.
- Product development duties assumed by VP Stacy Arnold, who reports directly to CEO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/805928/000080592824000037/0000805928-24-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/805928/000080592824000037/axgn-20240307.htm
  HTML page:      https://secwatch.observer/filing/0000805928-24-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer